
Cortellis Deals Intelligence
Pharma deals intelligence and analytics for partner identification, deal evaluation, and negotiation strategy.
Overview
Cortellis Deals Intelligence, from Clarivate, is a pharma deals analytics platform designed to help life sciences professionals evaluate partnership opportunities, negotiate with confidence, and drive company growth. It is built for business development teams, portfolio strategists, and deal-makers operating within the pharmaceutical and broader life sciences sector who need reliable, data-driven insights to inform their deal-making decisions.
By leveraging comprehensive pharma deals intelligence, Cortellis Deals Intelligence enables organizations to identify the best potential partners, benchmark deal terms, and empower their negotiating position across licensing, collaboration, and other strategic transactions.
Core Capabilities
- Access to in-depth pharma deals intelligence to support evaluation of potential partnership and licensing opportunities
- Tools to identify and assess the best partners for strategic collaborations within the life sciences industry
- Analytics designed to empower negotiations by providing context on deal structures, terms, and market benchmarks
- Insights that fuel company growth through informed portfolio strategy and business development decisions
Who It Serves
- Business development professionals seeking to identify and evaluate deal opportunities in the pharmaceutical sector
- Portfolio strategy teams requiring data-driven intelligence to guide licensing and partnership decisions
- Deal-makers looking to strengthen their negotiating position with comprehensive market and deal analytics
Cortellis Deals Intelligence is part of the broader Cortellis suite of life sciences intelligence solutions offered by Clarivate, sitting within the portfolio strategy and business development solutions portfolio alongside partner identification and deal-making tools.

